Taro Pharmaceutical Industries Ltd (TARO) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Industry, else..
 
Taro Pharmaceutical Industries Ltd  (NYSE: TARO)
 

Taro Pharmaceutical Industries Ltd Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TARO Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 2.07 % -8.02 % -5.13 % 2.84 %
Q / Q Revenue Growth (Q1 MRQ) - -7.22 % -5.98 % -3.84 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 2.07 % -0.08 % 0.12 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) - -2.04 % -1.31 % 0.6 %
Revenue 5 Year Average Growth -2.85 % 8.58 % 8.34 % 7.18 %


TARO's Growth Comparisons in IV. Quarter 2023




Taro Pharmaceutical Industries Ltd managed to grow Revenue by 2.07% year on year, in the fourth quarter 2023 to 573 millions, while Major Pharmaceutical Preparations industry fell by -8.02%, Healthcare sector decreased -5.13%. Slow fourth quarter sales, in the Major Pharmaceutical Preparations industry and Healthcare sector, were portrayed in Taro Pharmaceutical Industries Ltd results which underperformed overall market.

Sequentially company's Revenue were unchanged from the third quarter results. . Looking into annual growth, sales grew by -2.85% on average in last five years, while S & P 500's including only Businesses with the fourth quarter 2023 earnings reports, average yearly sales growth is 7.18%.


Growth Rates of TARO's Income in the fourth quarter 2023


TARO Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) -72.09 % -29.14 % -20.66 % -0.23 %
Sequential Operating Income Change (Q1 MRQ) - -20.01 % -19.45 % 1.73 %
Y / Y Operating Income Growth (Q1 TTM) -72.09 % 5.36 % -14.59 % 0.39 %
Sequential Operating Income Growth (Q1 TTM) -72.09 % -7.88 % -5.45 % -0.11 %
Operating Income 5 Year Avg. Change -43.33 % 1.49 % 3.96 % 8.85 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) -56.33 % -64.72 % -33.2 % -1.84 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) - -38.03 % -24.28 % 14.68 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) -56.33 % -23.46 % -40.68 % -3.85 %
Sequential Income from Cont. Ops. Change (Q1 TTM) -56.33 % -18.21 % -7.53 % -0.53 %
Income from Cont. Ops. 5 Year Avg. Change -34.46 % - - 9.74 %

TARO Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) -56.33 % -65.02 % -37.82 % -2.2 %
Q / Q Net Income Growth (Q1 MRQ) - -40.5 % -27.52 % 12.84 %
Y / Y Net Income Change (Q1 TTM) -56.33 % -21.3 % -37.84 % -4.53 %
Sequential Net Income Change (Q1 TTM) -56.33 % -18.01 % -9.15 % -0.6 %
Net Income 5 Year Avg. Growth -34.44 % - - 5.31 %

TARO's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) -56.13 % -31.92 % -33.2 % -1.84 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) - -35.58 % -24.28 % 14.68 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) -56.13 % - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) -56.13 % - - 0.17 %
EPS from Cont. Ops. 5 Year Avg. Growth -33.58 % - - 9.74 %



TARO EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) -56.13 % -32.49 % -37.82 % -2.2 %
Q / Q EPS Net Growth (Q1 MRQ) - -38.14 % -27.52 % 12.84 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - -9.85 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) -56.13 % - - -0.68 %
EPS Net 5 Year Avg. Change -33.58 % - - 5.31 %



As Taro Pharmaceutical Industries Ltd's income per share faded by -56.13% year on year in the fourth quarter, Major Pharmaceutical Preparations industry fell only by -32.49%, Taro Pharmaceutical Industries Ltd's fourth quarter performance was trailing Major Pharmaceutical Preparations, and underperformed the -37.82% EPS slide in the Healthcare sector. Weak fourth quarter income per share, in Major Pharmaceutical Preparations industry and within the Healthcare sector, were reflected in Taro Pharmaceutical Industries Ltd results which underperformed overall market.

Sequentially company's EPS were unchanged from the third quarter results. . Looking into annual growth, income per share grew by -33.58% on average in the last five years, while the S & P 500's including only the businesses with the fourth quarter 2023 financial results, average yearly income per share growth is 5.31%.

TARO Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - -63.09 % -57.26 % 2.48 %
Sequential Free Cash Flow Change (Q1 MRQ) - -65.86 % -70.64 % -61.87 %
Y / Y Free Cash Flow Change (Q1 TTM) - -24.78 % -30.51 % 4.91 %
Sequential Free Cash Flow Change (Q1 TTM) - -14.04 % -13.8 % -0.21 %
Free Cash Flow 5 Year Avg. Change -37.18 % 9.08 % 6.58 % 9.17 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - -
Sequential Net Cash Flow Change (Q1 MRQ) - 20.06 % 1904.62 % -
Y / Y Net Cash Flow Change (Q1 TTM) - - - -
Sequential Net Cash Flow Change (Q1 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - -2.24 % 7.19 % -33.15 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) 2.74 % 16.94 % 11.17 % 12.7 %
Sequential Capital Expenditures Change (Q1 MRQ) - -16.07 % -16.54 % -29.35 %
Y / Y Capital Expenditures Change (Q1 TTM) -46.82 % 13.64 % 11.46 % -4.94 %
Sequential Capital Expenditures Change (Q1 TTM) 2.65 % 3.99 % 2.47 % 0.78 %
Capital Expenditures 5 Year Avg. Change -9.56 % 13.35 % 12.45 % 8.47 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.